menu
    • menu

    Company profile for Verastem Oncology

    NEW Drugs in Dev: 8
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    When it comes to combatting cancer, we realize there are no “one size fits all” treatment approaches. We understand that every cancer lives in an intricate and complex microenvironment, creating significant unmet needs which must be addressed. It’s why we remain open to new ideas and selectively pursue science with the potential to make a significant impact for physicians, patients and their caregivers. We are focusing o...
    When it comes to combatting cancer, we realize there are no “one size fits all” treatment approaches. We understand that every cancer lives in an intricate and complex microenvironment, creating significant unmet needs which must be addressed. It’s why we remain open to new ideas and selectively pursue science with the potential to make a significant impact for physicians, patients and their caregivers. We are focusing on a portfolio of small molecule drugs inhibiting critical signaling pathways in cancer, including the phosphoinositide 3-kinase (PI3K) and focal adhesion kinase (FAK) pathways.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Verastem OncologyUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    117 Kendrick Street, Suite 500, Needham, Massachusetts 02494
    Telephone
    Telephone
    781-465-7936
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.verastem.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/verastemoncology/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/verastemoncolog?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Verastem Oncology Reports Q1 2026 Results and Updates
    Verastem Oncology Reports Q1 2026 Results and Updates

    07 May 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7304348

    FIRSTWORD PHARMA
    07 May 2026
    Share Share
    Verastem Oncology to Report Q1 2026 Results on May 7
    Verastem Oncology to Report Q1 2026 Results on May 7

    23 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260423119779/en/Verastem-Oncology-to-Report-First-Quarter-2026-Financial-Results-on-May-7-2026

    BUSINESSWIRE
    23 Apr 2026
    Share Share
    Verastem Data Shows 2-Year Follow-Up for Combo Therapy
    Verastem Data Shows 2-Year Follow-Up for Combo Therapy

    10 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260410817824/en/Verastem-Oncology-Announces-Two-Year-Median-Follow-Up-Data-on-AVMAPKI-FAKZYNJA-Combination-Therapy-avutometinib-capsules-defactinib-tablets-in-Recurrent-Low-Grade-Serous-Ovarian-Cancer-at-the-SGO-2026-Annual-Meeting-on-Womens-Cancers

    BUSINESSWIRE
    10 Apr 2026
    Share Share
    Verastem Announces Inducement Grants Under Nasdaq LR 5635(c)(4)
    Verastem Announces Inducement Grants Under Nasdaq LR 5635(c)(4)

    02 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260402851535/en/Verastem-Oncology-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4

    BUSINESSWIRE
    02 Apr 2026
    Share Share
    Verastem Oncology Announces Late Breaking And Regular Abstracts
    Verastem Oncology Announces Late Breaking And Regular Abstracts

    17 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260317972659/en/Verastem-Oncology-Announces-Late-Breaking-and-Regular-Abstracts-Accepted-for-Presentation-at-the-AACR-Annual-Meeting-2026

    BUSSINESSWIRE
    17 Mar 2026
    Share Share
    Verastem Oncology Reports Q4 and Full Year 2025 Financial Results
    Verastem Oncology Reports Q4 and Full Year 2025 Financial Results

    04 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260304011595/en/Verastem-Oncology-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Highlights-Recent-Business-Updates

    BUSSINESSWIRE
    04 Mar 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search